{"2501.11715": {"publish_time": "2025-01-20", "title": "GL-ICNN: An End-To-End Interpretable Convolutional Neural Network for the Diagnosis and Prediction of Alzheimer's Disease", "paper_summary": "Deep learning methods based on Convolutional Neural Networks (CNNs) have\nshown great potential to improve early and accurate diagnosis of Alzheimer's\ndisease (AD) dementia based on imaging data. However, these methods have yet to\nbe widely adopted in clinical practice, possibly due to the limited\ninterpretability of deep learning models. The Explainable Boosting Machine\n(EBM) is a glass-box model but cannot learn features directly from input\nimaging data. In this study, we propose a novel interpretable model that\ncombines CNNs and EBMs for the diagnosis and prediction of AD. We develop an\ninnovative training strategy that alternatingly trains the CNN component as a\nfeature extractor and the EBM component as the output block to form an\nend-to-end model. The model takes imaging data as input and provides both\npredictions and interpretable feature importance measures. We validated the\nproposed model on the Alzheimer's Disease Neuroimaging Initiative (ADNI)\ndataset and the Health-RI Parelsnoer Neurodegenerative Diseases Biobank (PND)\nas an external testing set. The proposed model achieved an area-under-the-curve\n(AUC) of 0.956 for AD and control classification, and 0.694 for the prediction\nof conversion of mild cognitive impairment (MCI) to AD on the ADNI cohort. The\nproposed model is a glass-box model that achieves a comparable performance with\nother state-of-the-art black-box models. Our code is publicly available at:\nhttps://anonymous.4open.science/r/GL-ICNN.", "paper_summary_zh": "<paragraph>\u57fa\u65bc\u5377\u7a4d\u795e\u7d93\u7db2\u8def (CNN) \u7684\u6df1\u5ea6\u5b78\u7fd2\u65b9\u6cd5\u5df2\u986f\u793a\u51fa\u6975\u5927\u7684\u6f5b\u529b\uff0c\u53ef\u6839\u64da\u5f71\u50cf\u8cc7\u6599\u6539\u5584\u963f\u8332\u6d77\u9ed8\u75c7 (AD) \u5931\u667a\u75c7\u7684\u65e9\u671f\u6e96\u78ba\u8a3a\u65b7\u3002\u7136\u800c\uff0c\u9019\u4e9b\u65b9\u6cd5\u5c1a\u672a\u5ee3\u6cdb\u61c9\u7528\u65bc\u81e8\u5e8a\u5be6\u52d9\u4e2d\uff0c\u9019\u53ef\u80fd\u662f\u7531\u65bc\u6df1\u5ea6\u5b78\u7fd2\u6a21\u578b\u7684\u53ef\u89e3\u91cb\u6027\u6709\u9650\u3002\u53ef\u89e3\u91cb\u63d0\u5347\u6a5f (EBM) \u662f\u500b\u73bb\u7483\u76d2\u6a21\u578b\uff0c\u4f46\u7121\u6cd5\u76f4\u63a5\u5f9e\u8f38\u5165\u5f71\u50cf\u8cc7\u6599\u4e2d\u5b78\u7fd2\u7279\u5fb5\u3002\u5728\u9019\u9805\u7814\u7a76\u4e2d\uff0c\u6211\u5011\u63d0\u51fa\u4e00\u500b\u7d50\u5408 CNN \u548c EBM \u7684\u65b0\u53ef\u89e3\u91cb\u6a21\u578b\uff0c\u7528\u65bc\u8a3a\u65b7\u548c\u9810\u6e2c AD\u3002\u6211\u5011\u958b\u767c\u4e86\u4e00\u7a2e\u5275\u65b0\u7684\u8a13\u7df4\u7b56\u7565\uff0c\u4ea4\u66ff\u8a13\u7df4 CNN \u7d44\u4ef6\u4f5c\u70ba\u7279\u5fb5\u8403\u53d6\u5668\uff0c\u4e26\u8a13\u7df4 EBM \u7d44\u4ef6\u4f5c\u70ba\u8f38\u51fa\u5340\u584a\uff0c\u4ee5\u5f62\u6210\u7aef\u5c0d\u7aef\u6a21\u578b\u3002\u6b64\u6a21\u578b\u5c07\u5f71\u50cf\u8cc7\u6599\u4f5c\u70ba\u8f38\u5165\uff0c\u4e26\u63d0\u4f9b\u9810\u6e2c\u548c\u53ef\u89e3\u91cb\u7684\u7279\u5fb5\u91cd\u8981\u6027\u6e2c\u91cf\u3002\u6211\u5011\u5728\u963f\u8332\u6d77\u9ed8\u75c7\u795e\u7d93\u5f71\u50cf\u5021\u8b70 (ADNI) \u8cc7\u6599\u96c6\u548c Health-RI Parelsnoer \u795e\u7d93\u9000\u5316\u75be\u75c5\u751f\u7269\u8cc7\u6599\u5eab (PND) \u4e0a\u9a57\u8b49\u4e86\u6240\u63d0\u51fa\u7684\u6a21\u578b\uff0c\u4f5c\u70ba\u5916\u90e8\u6e2c\u8a66\u96c6\u3002\u6240\u63d0\u51fa\u7684\u6a21\u578b\u5728 AD \u548c\u5c0d\u7167\u5206\u985e\u4e2d\u9054\u5230\u4e86 0.956 \u7684\u66f2\u7dda\u4e0b\u9762\u7a4d (AUC)\uff0c\u4e26\u5728 ADNI \u968a\u5217\u4e2d\u9810\u6e2c\u8f15\u5ea6\u8a8d\u77e5\u969c\u7919 (MCI) \u8f49\u5316\u70ba AD \u6642\u9054\u5230\u4e86 0.694\u3002\u6240\u63d0\u51fa\u7684\u6a21\u578b\u662f\u4e00\u500b\u73bb\u7483\u76d2\u6a21\u578b\uff0c\u5176\u6548\u80fd\u8207\u5176\u4ed6\u6700\u5148\u9032\u7684\u9ed1\u76d2\u6a21\u578b\u76f8\u7576\u3002\u6211\u5011\u7684\u7a0b\u5f0f\u78bc\u53ef\u5728\u4ee5\u4e0b\u7db2\u5740\u516c\u958b\u53d6\u5f97\uff1ahttps://anonymous.4open.science/r/GL-ICNN\u3002</paragraph>", "author": "Wenjie Kang et.al.", "authors": "Wenjie Kang, Lize Jiskoot, Peter De Deyn, Geert Biessels, Huiberdina Koek, Jurgen Claassen, Huub Middelkoop, Wiesje Flier, Willemijn J. Jansen, Stefan Klein, Esther Bron", "id": "2501.11715v1", "paper_url": "http://arxiv.org/abs/2501.11715v1", "repo": "null"}}